Abstracts

Search by keyword or author name.

Showing 852 abstracts.

Katherine Luzuriaga, M.D., Margaret McManus, B.S., Paula Britto, M.S., Hulin Wu, Ph.D., Jane C. Lindsey, Sc.D., Bryan C. Cole Smith, M.Ed., Lynne M. Mofenson, M.D., F.A.A.P., John L. Sullivan, M.D. Early Combination Antiretroviral Therapy of Vertical HIV-1 Infection: Viral Kinetics and Control of Viral Replication.
Margaret McManus, Mohan Somasundaran, Linda Lambrecht, Richard Hudson, Bobbie Graham, Lynne Mofenson, John L. Sullivan, Katherine Luzuriaga, the PACTG 356 Investigators. Early effective combination antiretroviral therapy alters HIV-1 persistence in HIV-infected infants. Presented at: IAS 2014.

Conference

IAS 2014
Early non-adherence to study drug associated with increased risk of TB in both INH and placebo groups in P1041.

Study

P1041
Tim Roy Cressey, B.Sc., Ph.D., Russell B. Van Dyke, M.D., Gonzague A. Jourdain, M.D., Thanyawee Puthanakit, M.D., M.H.S., Anuvat Roongpisuthipong, M.D., Jullapong Achalapong, M.D., Prapap Yuthavisuthi, M.D., Sinart Prommas, M.D., Nantasak Chotivanich, M.D., David E. Shapiro, Ph.D., Mark Mirochnick, M.D. Early postpartum pharmacokinetics of lopinavir when initiated intrapartum in Thai women: a substudy of the IMPAACT P1032 trial. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Conference

15th Conference on Retroviruses & Opportunistic Infections

Study

P1032
Nishaki Mehta, Margaret McManus, B.S., Robert Lin, M.D., Mohan Somasundaran, Ram Yogev, M.D., Ellen Gould Chadwick, M.D., Katherine Luzuriaga, M.D. Early Suppression of Viral Replication Preserves Measles-Specific Memory B Cells in Children. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Conference

16th Conference on Retroviruses & Opportunistic Infections
Ellen Gould Chadwick, M.D., Paul Palumbo, M.D., John H. Rodman, Pharm.D., Katherine Luzuriaga, M.D., Paula Britto, M.S., Ram Yogev, M.D. Early Therapy with Ritonavir (RTV), ZDV and 3TC in HIV-1 Infected Children 1-24 months of Age.
Sandra K. Burchett, M.D., M.S. Early Toxicity Experience in Combination Therapy of Advanced Pediatric HIV Disease.
Susie Andries Nogueira, M.D., Ph.D. Education of Caretakers of Pregnant Women: A Strategy to Reduce Vertical Transmission of HIV in Rio De Janeiro.
Courtney V. Fletcher, Pharm.D., Richard Brundage, Pharm.D., Ph.D., Terence Fenton, Ed.D., William D. Fiske, Ph.D., David Kornhauser, M.D., James McNamara, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Stuart E. Starr, M.D. Efavirenz (EFV) and Nelfinavir (NFV) Pharmacokinetics (PK) In HIV-Infected Children Participating In An Area Under the Curve (AUC) Controlled Trial.
Richard Brundage, Pharm.D., Ph.D., Courtney V. Fletcher, Pharm.D., Terence Fenton, Ed.D., William D. Fiske, Ph.D., Mark I. Becker, Pharm.D., Lynette Purdue, Pharm.D., Lynne M. Mofenson, M.D., F.A.A.P., James McNamara, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Stephen A. Spector, M.D., Stuart E. Starr, M.D. Efavirenz (EFV) and Nelfinavir (NFV) Pharmacokinetics (PK) In HIV-Infected Children Under Two Years Of Age.